Ledger.Open graph →
SEC Form D · Amendment · filed November 4, 2021

Aerami Therapeutics Holdings, Inc

Offering
$22.3M
Sold
$22.3M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Darlene J. Deptula-Hicks · DURHAM, NCDirectorAnne C. Whitaker · DURHAM, NCDirectorYehoshua S. Shainberg · New York, NYDirectorDavid A. Fennell · LONGUEUIL, Quebec, CanadaExec · DirectorK J. Bell · DURHAM, NCExecAmman Fenster · San Francisco, CADirectorAdrian A. Fleming · LONGUEUIL, Quebec, CanadaDirectorJohn S. Patton · DURHAM, NCDirectorDarlene J. Deptula-Hicks · DURHAM, NCDirectorJens Hoellerman · Senningerberg, LuxembourgExecAlap Shah · San Francisco, CADirectorNaman Shah · San Francisco, CAExec · DirectorBill S. Welch · DURHAM, NCDirectorK J. Bell · DURHAM, NCExecAlex S. Khowaylo · Allendale, NJDirectorBrandon Fluegel · Troy, MIExecSteve S. Thornton · DURHAM, NCExec · DirectorTimm J. Crowder · DURHAM, NCExecAnne Schieding · San Francisco, CADirectorMatthew Wiechert · Austin, TXDirectorAdam S. Stern · DURHAM, NCDirectorAlain N. Krushnisky · LONGUEUIL, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗